A client asks when fetal sex can be identified via ultrasound. What is the best response?

Rho(D) immune globulin provides passive immunization to Rh-negative mothers to prevent the development of permanent anti-D antibodies. If fetal erythropoiesis results in Rh-positive cells entering maternal circulation, the mother's immune system may recognize them as foreign. This prevents isoimmunization and subsequent hemolytic disease.

A. Increase iron levels: Rho(D) immune globulin is an antibody preparation and does not contain iron or influence hemoglobin synthesis. Iron deficiency is managed with oral supplements or parenteral iron sucrose. It has no role in correcting maternal anemia or mineral storage.

B. Prevent infection: The medication is not an antibiotic or an antiviral agent and does not protect against pathogenic microorganisms. Its sole function is to modulate the immune response to specific red blood cell antigens. It does not bolster general systemic immunity.

C. Prevent Rh sensitization: The primary goal is to hide fetal Rh-positive antigens from the maternal immune system. By clearing these cells before maternal B-cells can react, the drug prevents the production of IgG antibodies. This protects the current and future pregnancies from erythroblastosis fetalis.

D. Improve fetal growth: While preventing fetal anemia indirectly supports health, Rho(D) immune globulin is not a growth-promoting factor. Fetal growth is dependent on placental function and maternal nutrition. The medication specifically targets immunological compatibility rather than somatic developmental rates.

The placenta is a transient, highly vascular organ facilitating the intervillous exchange of gases and solutes between maternal and fetal circulations. It functions as a selective biological membrane that utilizes simple diffusion and active transport to sustain the fetus. Furthermore, it synthesizes essential hormones such as progesterone and lactogen.

A. It provides oxygen and nutrients: Maternal blood in the intervillous spaces transfers oxygen and glucose across the syncytiotrophoblast layer into fetal capillaries. This vital metabolic support is necessary for fetal organogenesis and cellular respiration throughout gestation. It serves as the primary life-support system for the developing fetus.

B. It produces RBCs: Erythropoiesis initially occurs in the yolk sac and later shifts to the fetal liver and spleen before the bone marrow takes over. The placenta facilitates the transport of iron required for hemoglobin synthesis but does not manufacture erythrocytes itself. Red cell production is an internal fetal process.

C. It blocks all harmful substances: Many teratogens, including ethanol, viruses like cytomegalovirus, and various pharmacological agents, readily cross the placental barrier via passive diffusion. It is not an absolute filter and cannot prevent the passage of low-molecular-weight toxins. This misconception can lead to dangerous prenatal exposures.

D. It stores fetal waste: Metabolic byproducts such as carbon dioxide and urea are continuously transferred back to the maternal circulation for excretion by the mother's lungs and kidneys. The placenta acts as a conduit rather than a storage reservoir for waste. Cumulative storage would result in fetal acidosis and toxicity.